iRhythm Announces Closing of $661.25 Million of 1.50% Convertible Senior Notes Due 2029, Including Full Exercise of Initial Purchasers’ $86.25 Million Option to Purchase Additional Notes
March 08, 2024 16:30 ET
|
iRhythm
SAN FRANCISCO, March 08, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (“iRhythm”) (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect,...
iRhythm Prices Upsized Offering of $575.0 Million of 1.50% Convertible Senior Notes Due 2029
March 04, 2024 23:42 ET
|
iRhythm
SAN FRANCISCO, March 04, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (“iRhythm”) (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect,...
iRhythm Announces Proposed Offering of $450.0 Million of Convertible Senior Notes
March 04, 2024 06:45 ET
|
iRhythm
SAN FRANCISCO, March 04, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (“iRhythm”) (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect,...
iRhythm collaborates with Epic to streamline access to Zio® service and drive more seamless connectivity between clinicians and patients
February 29, 2024 16:30 ET
|
iRhythm
iRhythm collaborates with Epic to streamline access to Zio® service and drive more seamless connectivity between clinicians and patients
iRhythm Technologies Announces Fourth Quarter and Full Year 2023 Financial Results
February 22, 2024 16:05 ET
|
iRhythm
SAN FRANCISCO, Feb. 22, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and...
iRhythm Technologies to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024
February 08, 2024 16:05 ET
|
iRhythm
SAN FRANCISCO, Feb. 08, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and...
iRhythm Technologies Shares Preliminary Fourth Quarter 2023 Highlights and Business Update at the 42nd Annual J.P. Morgan Healthcare Conference
January 08, 2024 08:30 ET
|
iRhythm
SAN FRANCISCO, Jan. 08, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and...
Largest Ever Real-World Evidence Study of Ambulatory Cardiac Monitoring Demonstrates Clinical Superiority of iRhythm's Zio Long-Term Continuous Monitoring Service
January 05, 2024 08:05 ET
|
iRhythm
CAMELOT is the largest published real-world comparative effectiveness analysis of ambulatory cardiac monitoring.
iRhythm Technologies erhält CE-Kennzeichnung der Europäischen Union gemäß Medizinprodukteverordnung (EU-MDR) für Zio®-Monitor und ZEUS-System
January 03, 2024 20:59 ET
|
iRhythm
SAN FRANCISCO, Jan. 04, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), ein führendes Unternehmen im Bereich der digitalen Gesundheit, das sich auf die Entwicklung zuverlässiger...
iRhythm Technologies reçoit le marquage CE en vertu du règlement relatif aux dispositifs médicaux (règlement UE relatif aux DM) pour son moniteur Zio® et son système ZEUS
January 03, 2024 20:59 ET
|
iRhythm
SAN FRANCISCO, 04 janv. 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ : IRTC), une société leader dans le domaine des soins de santé numériques qui contribue à créer des solutions...